DiLumen C – Lumendi

LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET

LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET ZUG, Switzerland, Oct. 29, 2025 /PRNewswire/ Lumendi AG, a leader in advanced endoluminal technologies, today… Continue reading

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR INNOVATIVE DILUMEN^™ EIP DEVICE MODIFICATION TO IMPROVE TISSUE RETRACTION DURING THERAPEUTIC ENDOSCOPY

With recent regulatory approvals in Europe, Lumendi has established distribution in the UK, France and Italy and has conducted successful procedures with clinicians in each country.

500 THERAPEUTIC PROCEDURES USING DILUMEN^™ EIP COMPLETED ACROSS U.S., EUROPE AND ASIA

WESTPORT, CONN, OCTOBER 4, 2018 − Connecticut-based medical device innovator Lumendi, LLC reports that more than 500 therapeutic procedures by more than 40 endoscopists and colorectal surgeons have been completed… Continue reading

LUMENDI OPENS EU MARKET FOR DILUMEN EIP^™

CE Certification Confirms Device Conforms to Medical Device Directive 93/42/EEC BUCKINGHAMSHIRE, UK, JULY 17, 2018 -- Lumendi Ltd., a privately held innovative medical device company, today announced that its subsidiary,… Continue reading

FLEXIBLE ENDOSCOPIC DOUBLE BALLOON PLATFORM: FROM CONCEPT TO HUMAN FEASIBILITY TRIAL

Flexible Endoscopic Double Balloon Platform: from concept to human feasibility trial. Sam Sharma*, Kota Momose, Toyooki Sonoda, Reem Z. Sharaiha Weill Cornell Medical College, New York, NY Background: Despite the… Continue reading

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN Is^™ ENDOLUMENAL INTERVENTIONAL SCISSORS

Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, May 29, 2018 − Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading